My Breast Cancer is stable but not shrinking — is treatment still working
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Stable Disease in Breast Cancer Treatment
This is an excellent and important question. Let me explain what "stable" means and how oncologists evaluate whether treatment is working.
What "Stable Disease" Actually Means
When your doctor says your cancer is stable, they mean the tumor size hasn't significantly changed—it's not growing AND it's not shrinking. This might feel frustrating if you were hoping for shrinkage, but stable disease is actually a positive outcome in cancer treatment.
Here's why:
The Clinical Goal Framework: Oncologists measure treatment success using several outcomes, not just tumor shrinkage:
- Complete response (tumor disappears)
- Partial response (tumor shrinks by 30% or more)
- Stable disease (tumor stays roughly the same size)
- Progressive disease (tumor grows)
According to NCCN Breast Cancer Guidelines, stable disease is considered a beneficial treatment response—it means the cancer is NOT progressing while you're receiving therapy.
Why Stable Disease Matters
Stopping the growth is a win. Without treatment, your cancer would likely continue growing. By keeping it stable, your treatment is:
- Preventing progression
- Buying time for the medication to work at the cellular level
- Potentially allowing your immune system to respond
- Maintaining your quality of life while controlling disease
Some patients experience a "delayed response"—meaning tumors stabilize first, then shrink over additional treatment cycles. This is well-documented in breast cancer care.
Important Questions to Ask Your Oncologist
Since your disease is stable, these specific questions will help you understand your situation better:
-
"How long has the tumor been stable, and what does that timeline tell us?" (Stability over months is more meaningful than weeks)
-
"Are there any tumor markers or blood tests showing improvement even if the size hasn't changed?" (Sometimes molecular markers improve before imaging shows shrinkage)
-
"Based on my specific type of breast cancer [hormone receptor status, HER2 status, etc.], is stable disease the expected pattern for this treatment?" (Some treatments work differently depending on your cancer subtype)
-
"Should we continue the current treatment, or are there reasons to consider adjusting it?" (Your doctor may recommend continuing, switching, or adding therapy)
-
"What would we be looking for at the next scan to know if treatment is working as expected?" (This helps you understand the plan going forward)
The Bigger Picture
According to the American Cancer Society, treatment goals for advanced or metastatic breast cancer often focus on:
- Controlling disease progression
- Maintaining quality of life
- Extending survival
- Managing side effects
Stable disease directly supports these goals. It's not the same as "not working"—it's working to prevent progression.
Next Steps
Ask your oncologist to review:
- How long the disease has been stable
- Your specific breast cancer subtype (ER/PR/HER2 status) and whether the current treatment matches it
- Tumor markers (like CA 27.29) if available
- The treatment plan going forward
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Im interested in integrative options to pysh cancer back in remission. No need tO Rely of NCCN, use data from...
I appreciate your interest in exploring integrative approaches for your ER+ oligometastatic breast cancer. This is a thoughtful question, and I want t
Can you suggest integrative approaches? Possibly i can stop the progression. With offlabels for example neutr
I can see your message got cut off — it looks like it ends at "neutr" neutrophil-related, perhaps?. Before I give you a comprehensive answer about in
What lifestyle changes are recommended for Breast Cancer patients
Given your ER-positive oligometastatic breast cancer and your current treatment with ribociclib, lifestyle modifications play an important supporting
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I want to make sure I'm giving you the most helpful educational information. Let me clarify what I'm seeing in your message — it looks like it got cut
How do I find the best clinical trial for breast cancer
Clinical trials can be an important option to explore as part of your breast cancer treatment plan. Here's how to approach finding one that might be r